Effects of paeoniflorin derivatives on scopolamine-induced amnesia using a passive avoidance task in mice; structure-activity relationship. 1998

A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
Research Institute for Wakan-Yaku (Traditional Sino-Japanese Medicines), Toyama Medical and Pharmaceutical University, Japan.

Paeoniflorin (1) and its derivatives having in common a cage-like pinane skeleton with hemiketal-acetal system, were evaluated for their effects on memory impairment induced by scopolamine in mice using a step-down type passive avoidance task. In the test session, 1 and its derivatives were intraperitoneally (i.p.) administered at doses of 0.002, 0.01, 0.02 and 0.2 mmol/kg, and 30 min later (15 min before the experiment), scopolamine (1 mg/kg, i.p.) was given. These compounds showed dose-dependent attenuation in a dose range of 0.002-0.02 mmol/kg and also enhancement of scopolamine-induced decrease in step-down latency. The effects of these compounds, except that of 2',3',4',5'-O-tetraacetyl-3-O-methylpaeoniflorin (8), followed a bell-shaped dose response profile. 8-Debenzoyl-6-deglucosyl-3-O-methylpaeoniflorin (6) showed no significant increase in the step-down latency at all tested doses. Maximum step-down latency was obtained by 3-O-methylpaeoniflorin (3) and 2',3,3',4',5'-penta-O-methylpaeoniflorin (7) (the minimal effective dose was 0.002 mmol/kg). Relative to 3, debenzoylation, as in 8-debenzoyl-3-O-methylpaeoniflorin (4), slightly increased the latency, while deglucosylation, as in 6-deglucosyl-3-O-methylpaeoniflorin (5), significantly reduced the prolongation of latency. Removal of both glucose and benzoyl moieties resulted in the loss of activity as seen in 6. These results revealed that, in addition to the cage-like pinane skeleton, the benzoyl and the glucosyl moieties are important structural elements of the paeoniflorin skeleton as its effects on scopolamine-induced amnesia.

UI MeSH Term Description Entries
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D001952 Bridged-Ring Compounds Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections. Bridged Compounds,Bridged Ring Compounds
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D005960 Glucosides A GLYCOSIDE that is derived from GLUCOSE. Glucoside
D000647 Amnesia Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7) Amnesia, Dissociative,Amnesia, Global,Amnesia, Hysterical,Amnesia, Tactile,Amnesia, Temporary,Amnesia-Memory Loss,Amnestic State,Amnesia Memory Loss,Amnesia-Memory Losses,Amnesias,Amnesias, Dissociative,Amnesias, Global,Amnesias, Hysterical,Amnesias, Tactile,Amnesias, Temporary,Amnestic States,Dissociative Amnesia,Dissociative Amnesias,Global Amnesia,Global Amnesias,Hysterical Amnesia,Hysterical Amnesias,State, Amnestic,States, Amnestic,Tactile Amnesia,Tactile Amnesias,Temporary Amnesia,Temporary Amnesias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D001565 Benzoates Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure. Benzoate,Benzoic Acids,Acids, Benzoic
D012601 Scopolamine An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Its many uses include an anesthetic premedication, the treatment of URINARY INCONTINENCE and MOTION SICKNESS, an antispasmodic, and a mydriatic and cycloplegic. Hyoscine,Scopolamine Hydrobromide,Boro-Scopol,Isopto Hyoscine,Kwells,Scoburen,Scopace,Scopoderm TTS,Scopolamine Cooper,Transderm Scop,Transderm-V,Travacalm HO,Vorigeno,Boro Scopol,Transderm V

Related Publications

A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
February 2004, Pharmacological research,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
November 1988, Behavioral and neural biology,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
January 1993, Brain research bulletin,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
August 1995, European journal of pharmacology,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
May 1992, Behavioral and neural biology,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
January 1986, Psychopharmacology,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
September 1968, Psychopharmacologia,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
February 1967, Psychological reports,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
June 2016, European journal of pharmacology,
A A Abdel-Hafez, and M R Meselhy, and N Nakamura, and M Hattori, and H Watanabe, and Y Murakami, and M A El-Gendy, and N M Mahfouz, and T A Mohamed
June 2018, Nutrients,
Copied contents to your clipboard!